NCT03690063 Nice Human Immunodeficiency Virus (HIV) Cohort
| NCT ID | NCT03690063 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Human Immunodeficiency Virus |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 1996-01-01 |
| Primary Completion | 1996-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 1996-01-01 with a primary completion date of 1996-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Historically, the database on the HIV was organized within the framework of the medico-economic file of the human immunodeficiency (DMI-2), introduced jointly by the Direction of Hospitals (Mission AIDS) and the INSERM at the end of the 80s. Today this database is fed via the computerized medical record NADIS. Most part of the research works on the theme of the HIV take support on this database (DAD, EuroAIDS, Neuradapt).
Eligibility Criteria
Inclusion Criteria: * Enrol consecutive patients with a scheduled visit in the outpatient clinic (regardless of CD4 cell count and ART status). Exclusion Criteria: \-
Contact & Investigator
Christian PRADIER, Pr
✉ pradier.c@chu-nice.frFrequently Asked Questions
Who can join the NCT03690063 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Human Immunodeficiency Virus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03690063 currently recruiting?
Yes, NCT03690063 is actively recruiting participants. Contact the research team at pradier.c@chu-nice.fr for enrollment information.
Where is the NCT03690063 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT03690063 clinical trial?
NCT03690063 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 2,000 participants.